Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
133.9 USD | -1.95% | -4.60% | +7.87% |
Apr. 16 | Dexcom Insider Sold Shares Worth $274,242, According to a Recent SEC Filing | MT |
Apr. 15 | BTIG Adjusts DexCom's Price Target to $156 From $150 | MT |
Business Summary
The United States accounts for 72.5% of net sales.
Number of employees: 9,550
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Distributor
85.5
%
| 2,471 | 84.9 % | 3,096 | 85.5 % | +25.29% |
Direct
14.5
%
| 439 | 15.1 % | 527 | 14.5 % | +19.98% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
72.5
%
| 2,142 | 73.6 % | 2,625 | 72.5 % | +22.56% |
International
27.5
%
| 768 | 26.4 % | 997 | 27.5 % | +29.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 | |
Shelly Selvaraj
CTO | Chief Tech/Sci/R&D Officer | 65 | 16-04-30 |
Jacob Leach
COO | Chief Operating Officer | 46 | 04-02-29 |
Donald Abbey
CTO | Chief Tech/Sci/R&D Officer | 57 | 16-04-30 |
Andrew Balo
CTO | Chief Tech/Sci/R&D Officer | 76 | 02-01-31 |
Sean Christensen
IRC | Investor Relations Contact | - | - |
Paul Flynn
PRN | Corporate Officer/Principal | 55 | 15-09-30 |
Sadie Stern
HRO | Human Resources Officer | 49 | 20-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Steven Altman
BRD | Director/Board Member | 62 | 13-11-06 |
Bridgette Heller
BRD | Director/Board Member | 63 | 19-09-12 |
Richard Collins
BRD | Director/Board Member | 67 | 17-03-08 |
Kyle Malady
BRD | Director/Board Member | 56 | 20-10-10 |
Barbara Kahn
BRD | Director/Board Member | 71 | 11-03-31 |
Karen Dahut
BRD | Director/Board Member | 60 | 20-08-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 407,315,421 | 383,922,932 ( 94.26 %) | 21,800,000 ( 5.352 %) | 94.26 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Dexcom Operating Ltd.
Dexcom Operating Ltd. Financial ConglomeratesFinance Part of DexCom, Inc., DexCom Operating Ltd. functions as an investment holding British company. The private company is based in Reading, UK and was founded in 2015. |
Financial Conglomerates
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.82% | 52.63B | |
-3.91% | 105B | |
-4.84% | 66.74B | |
+15.82% | 47.48B | |
0.00% | 39.68B | |
+8.08% | 27.78B | |
-0.56% | 26.27B | |
+3.80% | 26.11B | |
+12.35% | 25.38B | |
-0.30% | 25.08B |
- Stock Market
- Equities
- DXCM Stock
- Company DexCom, Inc.